ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.69
0.27%
US Tech 100
20,240.00
-0.65%
S&P 500
5,998.74
-0.38%
US Dollar vs CAD
1.40251
-0.01%
Bitcoin
95,279.30
-0.74%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX
  6. Willow Biosciences Inc (WLLW)

  7. Willow Biosciences Inc (WLLW) News

WLLW

Willow Biosciences (WLLW)

Willow Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:WLLW
DateTimeSourceHeadlineSymbolCompany
11/12/20246:00AMPR Newswire (Canada)WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
11/12/20246:00AMPR Newswire (US)WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
11/07/20246:00AMPR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIOTSX:WLLWWillow Biosciences Inc
11/07/20246:00AMPR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIOTSX:WLLWWillow Biosciences Inc
09/18/20246:00PMPR Newswire (Canada)WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
09/18/20246:00PMPR Newswire (US)WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
09/05/202412:00PMAllPennyStocks.comBiotech on An Upswing Following Licensing and Royalty AgreementTSX:WLLWWillow Biosciences Inc
09/05/20246:00AMPR Newswire (US)WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.TSX:WLLWWillow Biosciences Inc
09/05/20246:00AMPR Newswire (Canada)WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.TSX:WLLWWillow Biosciences Inc
08/12/20246:00AMPR Newswire (US)WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
08/12/20246:00AMPR Newswire (Canada)WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
08/07/20246:00AMPR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDYTSX:WLLWWillow Biosciences Inc
08/07/20246:00AMPR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDYTSX:WLLWWillow Biosciences Inc
07/26/20244:48PMPR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTSTSX:WLLWWillow Biosciences Inc
07/18/20247:49AMPR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF UNITSTSX:WLLWWillow Biosciences Inc
06/26/20243:30PMPR Newswire (Canada)WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAMTSX:WLLWWillow Biosciences Inc
06/26/20243:30PMPR Newswire (US)WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAMTSX:WLLWWillow Biosciences Inc
06/03/20246:00AMPR Newswire (Canada)WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLIONTSX:WLLWWillow Biosciences Inc
05/30/20246:00AMPR Newswire (US)WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
05/30/20246:00AMPR Newswire (Canada)WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
05/13/20246:00AMPR Newswire (US)WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
05/13/20246:00AMPR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
03/28/20246:30PMPR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFTSX:WLLWWillow Biosciences Inc
03/28/20246:30PMPR Newswire (US)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFTSX:WLLWWillow Biosciences Inc
02/29/20245:00PMPR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECTSX:WLLWWillow Biosciences Inc
02/29/20245:00PMPR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECTSX:WLLWWillow Biosciences Inc
02/20/20245:00PMPR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSTSX:WLLWWillow Biosciences Inc
02/20/20245:00PMPR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSTSX:WLLWWillow Biosciences Inc
01/31/20246:00AMPR Newswire (US)WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
01/31/20246:00AMPR Newswire (Canada)WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
 Showing the most relevant articles for your search:TSX:WLLW

Your Recent History

USOTC
ASII
Accredited Solutions (PK)
USOTC
SANP
Santo Mining (CE)
USOTC
TSOI
Therapeutic Solutions (PK)
NYSE
IONQ
IonQ
USOTC
ERHE
ERHC Energy (CE)
NASDAQ
NB
NioCorp Developments
NASDAQ
AMRN
Amarin
USOTC
MONI
Moon Equity (PK)
USOTC
GDVM
Global Developments (PK)
NASDAQ
ENTA
Enanta Pharmaceuticals
USOTC
ENZC
Enzolytics (PK)
USOTC
AZRH
Azure (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
AABB
Asia Broadband (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49